CD4 and HIV-1 infection: Therefore, this report suggests that endogenous APOBEC3 proteins expressed in human CD4+ T cells can abrogate HIV-1 infection in vivo as a result of accumulating G-to-A mutations in proviral DNA, and that Vif counteracts this robust anti-viral activity of endogenous APOBEC3 proteins even in vivo.